Glucagon-like peptide-1 receptor agonists in patients treated with antipsychotics

INTRODUCTION: Glucagon-like peptide-1 (GLP-1) is an endogenous peptide that stimulates insulin secretion and decreases glucagon secretion. The use of GLP-1 receptor agonists (GLP-1RA) showed efficacy reducing the weight and glucose levels in patients with and without type 2 diabetes. This effect was...

Descripción completa

Detalles Bibliográficos
Autores principales: Delgado, A., Velosa, J., Avelar, R., Franco, J., Heitor, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479982/
http://dx.doi.org/10.1192/j.eurpsy.2021.2050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479982/
http://dx.doi.org/10.1192/j.eurpsy.2021.2050

Ejemplares similares